Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature.

  title={Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature.},
  author={Stefan Reuter and Bj{\"o}rn E-O Jensen and Klaus Buttenschoen and Wolfgang Kratzer and Peter Kern},
  journal={The Journal of antimicrobial chemotherapy},
  volume={46 3},
Mebendazole and albendazole are the drugs of choice for the treatment of alveolar echinococcosis. In this open-labelled observational study we present and evaluate the outcome of long-term treatment with these drugs and present results of different treatment regimens. Thirty-five patients were started on either mebendazole or albendazole at the beginning of 1992 and followed for an average of 39 months (range 12-79 months). Treatment was classed as successful if the disease had not progressed… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 51 extracted citations

Hydatid Liver Disease

Dr. Iqbal Haider, Mohammad Humayun, M A Bangash, Wazir Mohammad
View 2 Excerpts


Publications referenced by this paper.
Showing 1-10 of 32 references

Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis (preliminary results).

The American journal of tropical medicine and hygiene • 1990
View 4 Excerpts
Highly Influenced


A. Davis, Z. S. Pawlowski, H. Dixon
Journal of Antimicrobial Chemotherapy • 1998

Continuous or intermittent treatment with albendazole

Y. H. Liu
Archivos Internacionales de la Hidatidosis [XVIII International Congress of Hydatidology] • 1997

Cestodes. Echinococcus.

Gastroenterology clinics of North America • 1996

Similar Papers

Loading similar papers…